Advanced
  Home Compare Reports

Comparison with Similar Reports

Veterinary Reference Laboratory Market by Service Type (Clinical Chemistry, Hematology, Immunodiagnostics, Molecular Diagnostics, Urinalysis), Applica...

Publisher:        MarketsandMarkets

# of Pages:        253

Rating: 

1 User License $4,950

Publication Date:  December, 2021

Price:       $4,950 / User License




1 INTRODUCTION 30
1.1 OBJECTIVES OF THE STUDY 30
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS AND EXCLUSIONS 31
1.3 MARKET SCOPE 31
1.3.1 MARKETS COVERED 32
FIGURE 1 VETERINARY REFERENCE LABORATORY MARKET SEGMENTATION 32
FIGURE 2 VETERINARY REFERENCE LABORATORY MARKET, BY REGION 32
1.4 YEARS CONSIDERED FOR THE STUDY 33
1.5 CURRENCY 33
TABLE 1 STANDARD CURRENCY CONVERSION RATES 33
1.6 LIMITATIONS 34
1.7 STAKEHOLDERS 34
1.8 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 3 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.1.1 Key data from secondary sources 38
2.1.2 PRIMARY DATA 38
FIGURE 4 PRIMARY SOURCES 38
2.1.2.1 Key data from primary sources 39
2.1.2.2 Key industry insights 40
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 40
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 41
2.2 MARKET SIZE ESTIMATION 41
FIGURE 7 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 42
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES 42
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: VETERINARY REFERENCE LABORATORY MARKET (2020) 43
FIGURE 10 TOP-DOWN APPROACH 44
FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN THE VETERINARY REFERENCE LABORATORY MARKET (2021–2026): IMPACT ON MARKET GROWTH & CAGR 45
FIGURE 12 CAGR PROJECTIONS 45
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 47
FIGURE 13 MARKET DATA TRIANGULATION METHODOLOGY 47
2.4 MARKET SHARE ESTIMATION 48
2.5 ASSUMPTIONS FOR THE STUDY 48
3 EXECUTIVE SUMMARY 50
FIGURE 14 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE,
2021 VS. 2026 (USD MILLION) 50
FIGURE 15 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,
2021 VS. 2026 (USD MILLION) 51
FIGURE 16 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION) 51
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE VETERINARY REFERENCE LABORATORY MARKET 52
4 PREMIUM INSIGHTS 54
4.1 VETERINARY REFERENCE LABORATORY MARKET OVERVIEW 54
FIGURE 18 GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 54
4.2 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE & COUNTRY (2020) 55
FIGURE 19 IMMUNODIAGNOSTICS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC VETERINARY REFERENCE LABORATORY MARKET IN 2020 55
4.3 VETERINARY REFERENCE LABORATORY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 56
FIGURE 20 CHINA TO REGISTER THE HIGHEST GROWTH IN THE VETERINARY REFERENCE LABORATORY MARKET DURING THE FORECAST PERIOD 56
4.4 VETERINARY REFERENCE LABORATORY MARKET: REGIONAL MIX 56
FIGURE 21 NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET IN 2026 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS 57
FIGURE 22 VETERINARY REFERENCE LABORATORY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 57
5.2.1 DRIVERS 58
5.2.1.1 Growth in the companion animal population 58
FIGURE 23 PET POPULATION & PET OWNERSHIP, 2017 VS. 2018 VS. 2019 58
5.2.1.2 Growing demand for pet insurance and increasing pet care expenditure 59
FIGURE 24 US: PET INDUSTRY EXPENDITURE 59
TABLE 2 NORTH AMERICA: PET HEALTH INSURANCE MARKET,
2012–2018 (USD MILLION) 59
5.2.1.3 Increasing number of veterinary practitioners in developed economies 60
FIGURE 25 NORTH AMERICA: NUMBER OF VETERINARY PRACTITIONERS 60
FIGURE 26 EUROPE: NUMBER OF VETERINARY PRACTITIONERS 60
5.2.1.4 Increasing demand for animal-derived food products 61
TABLE 3 PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT AND MILK IN DEVELOPED AND DEVELOPING REGIONS 61
FIGURE 27 ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 62
FIGURE 28 ASIA: COUNTRY-LEVEL PRODUCTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS) 62
5.2.1.5 Increasing incidence of transboundary and zoonotic diseases 62
5.2.2 RESTRAINTS 63
5.2.2.1 Increasing pet care costs 63
FIGURE 29 ANNUAL ROUTINE VETERINARY VISIT EXPENDITURE: DOGS & CATS 63
5.2.2.2 Growing demand for rapid tests, POC testing, and portable instruments 64
5.2.3 OPPORTUNITIES 64
5.2.3.1 Untapped emerging markets 64
5.2.3.2 Public-private partnerships in veterinary health 64
5.2.3.3 Increased use of PCR testing panels to rule out COVID-19 in animals 65
5.2.4 CHALLENGES 65
5.2.4.1 Low awareness in emerging markets 65
5.2.4.2 Shortage of veterinarians in emerging markets 65
FIGURE 30 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY (2016 VS. 2018) 66
5.2.4.3 Weak functional and infrastructural capacities 66
6 INDUSTRY INSIGHTS 67
6.1 TECHNOLOGY ANALYSIS 67
6.1.1 DEVELOPMENT OF PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES 67
TABLE 4 LAUNCH OF POINT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC TESTS 67
6.1.2 DEVELOPMENT OF RAPID AND SENSITIVE VETERINARY LABORATORY TESTS 67
6.2 INDUSTRY TRENDS 68
6.2.1 ADOPTION OF MULTIPLE TESTING PANELS 68
TABLE 5 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS 68
6.2.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 68
6.2.3 INNOVATION IN DIAGNOSTIC PRODUCTS FOR QUALITY SERVICE IMPLEMENTATION 69
6.3 DISEASE TRENDS 69
6.3.1 LIVESTOCK ANIMALS 69
6.3.1.1 Avian influenza (AI) 69
6.3.1.2 African swine fever (ASF) 69
6.3.1.3 Bovine babesiosis (BB) 70
6.3.1.4 Peste des petits ruminants (PPR) 70
6.3.1.5 West Nile virus (WNV) 70
 
6.3.2 COMPANION ANIMALS 70
6.3.2.1 Zoonotic diseases 70
TABLE 6 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS ACROSS THE GLOBE 70
6.3.2.2 Obesity & diabetes 71
6.4 REGULATORY ANALYSIS 72
6.5 PRICING ANALYSIS 72
TABLE 7 PRICING ANALYSIS, 2019 (USD) 72
6.6 ECOSYSTEM MAPPING 73
FIGURE 31 VETERINARY REFERENCE LABORATORY MARKET: ECOSYSTEM MARKET MAP 74
6.7 PATENT ANALYSIS 74
6.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY REFERENCE LABORATORIES 74
FIGURE 32 GLOBAL PATENT PUBLICATION TRENDS IN THE VETERINARY REFERENCE LABORATORY MARKET, 2015–2020 75
6.8 IMPACT OF THE COVID-19 PANDEMIC ON THE VETERINARY REFERENCE LABORATORY MARKET 75
TABLE 8 GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY
ACQUIRED SARS-COV-2 (COVID-19) INFECTIONS IN ANIMALS 75
FIGURE 33 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020 76
7 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE 77
7.1 INTRODUCTION 78
TABLE 9 VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 78
7.1.1 IMPACT OF COVID-19 ON THE TYPE OF TECHNOLOGIES USED 78
7.2 CLINICAL CHEMISTRY 78
7.2.1 INCREASING PET HEALTHCARE EXPENDITURE AND THE RISING NUMBER OF SCREENING TESTS PERFORMED TO DRIVE MARKET GROWTH 78
TABLE 10 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2019–2026 (USD MILLION) 79
7.3 HEMATOLOGY 80
7.3.1 HEMATOLOGY SERVICES ARE USED TO MEASURE BLOOD CELL COUNT AND COAGULATION TIME OF BLOOD IN ANIMALS 80
TABLE 11 VETERINARY REFERENCE LABORATORY MARKET FOR HEMATOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 80
7.4 IMMUNODIAGNOSTICS 81
7.4.1 LOW COST AND PROCEDURAL COMPLEXITY ARE DRIVING THE GROWTH OF THIS SEGMENT 81
TABLE 12 VETERINARY REFERENCE LABORATORY MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 81
7.5 MOLECULAR DIAGNOSTICS 82
7.5.1 GROWING DEMAND FOR RELIABLE AND RAPID METHODS OF GENETIC DISORDER DETECTION TO DRIVE MARKET GROWTH 82
TABLE 13 VETERINARY REFERENCE LABORATORY MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION) 82
7.6 URINALYSIS 83
7.6.1 RISING OCCURRENCE OF KIDNEY DISEASES IN CATS AND DOGS TO SUPPORT THE GROWTH OF THIS SEGMENT 83
TABLE 14 VETERINARY REFERENCE LABORATORY MARKET FOR URINALYSIS,
BY COUNTRY, 2019–2026 (USD MILLION) 84
7.7 OTHER SERVICES 85
TABLE 15 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER SERVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 85
8 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION 86
8.1 INTRODUCTION 87
TABLE 16 VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 87
8.1.1 IMPACT OF COVID-19 ACROSS DIFFERENT APPLICATION AREAS 87
8.2 CLINICAL PATHOLOGY 88
8.2.1 CLINICAL PATHOLOGY SEGMENT DOMINATES THE VETERINARY REFERENCE LABORATORY APPLICATIONS MARKET 88
TABLE 17 VETERINARY REFERENCE LABORATORY MARKET FOR CLINICAL PATHOLOGY, BY COUNTRY, 2019–2026 (USD MILLION) 88
8.3 BACTERIOLOGY 89
8.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES WILL DRIVE THE MARKET FOR BACTERIOLOGY 89
TABLE 18 VETERINARY REFERENCE LABORATORY MARKET FOR BACTERIOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 89
8.4 PARASITOLOGY 90
8.4.1 INCREASING PREVALENCE OF PARASITIC DISEASES WILL SUPPORT THE GROWTH OF THIS APPLICATION SEGMENT 90
TABLE 19 VETERINARY REFERENCE LABORATORY MARKET FOR PARASITOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 90
8.5 VIROLOGY 91
8.5.1 GROWING NUMBER OF VIRAL OUTBREAKS IS CONTRIBUTING TO THE GROWTH OF THIS SEGMENT 91
TABLE 20 VETERINARY REFERENCE LABORATORY MARKET FOR VIROLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 91
8.6 PRODUCTIVITY TESTING 92
8.6.1 INCREASING FOCUS ON ENSURING THE QUALITY OF MILK AND MEAT IS DRIVING THE DEMAND FOR PRODUCTIVITY TESTING 92
TABLE 21 VETERINARY REFERENCE LABORATORY MARKET FOR PRODUCTIVITY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 92
8.7 PREGNANCY TESTING 93
8.7.1 FOCUS ON BREEDING AND HERD MANAGEMENT PROGRAMS WILL DRIVE THE GROWTH OF THIS SEGMENT 93
TABLE 22 VETERINARY REFERENCE LABORATORY MARKET FOR PREGNANCY TESTING, BY COUNTRY, 2019–2026 (USD MILLION) 93
8.8 TOXICOLOGY TESTING 94
8.8.1 REGULATION OF ANIMAL HEALTH TO AVOID FEED AND ANIMAL-DERIVED FOOD CONTAMINATION IS DRIVING MARKET GROWTH 94
TABLE 23 VETERINARY REFERENCE LABORATORY MARKET FOR TOXICOLOGY,
BY COUNTRY, 2019–2026 (USD MILLION) 94
9 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE 95
9.1 INTRODUCTION 96
TABLE 24 VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE,
2019–2026 (USD MILLION) 96
9.1.1 IMPACT OF COVID-19 ON TESTING IN ANIMALS 96
9.2 COMPANION ANIMALS 96
TABLE 25 POPULATION OF SMALL COMPANION ANIMALS, BY COUNTRY,
2012–2019 (MILLION) 97
TABLE 26 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 97
TABLE 27 VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 98
9.2.1 DOGS 98
9.2.1.1 Increasing incidence of zoonotic, chronic, and parasitic diseases in dogs to drive the growth of this market segment 98
FIGURE 34 NUMBER OF PET DOGS IN CHINA FROM 2013 TO 2022 (IN MILLION) 99
TABLE 28 VETERINARY REFERENCE LABORATORY MARKET FOR DOGS, BY COUNTRY, 2019–2026 (USD MILLION) 100
9.2.2 CATS 100
9.2.2.1 Rising prevalence of infectious diseases in cats to drive the growth of this market segment 100
TABLE 29 VETERINARY REFERENCE LABORATORY MARKET FOR CATS, BY COUNTRY, 2019–2026 (USD MILLION) 101
9.2.3 HORSES 102
9.2.3.1 Global equine population has witnessed slow growth in recent years 102
TABLE 30 VETERINARY REFERENCE LABORATORY MARKET FOR HORSES, BY COUNTRY, 2019–2026 (USD MILLION) 102
9.2.4 OTHER COMPANION ANIMALS 103
TABLE 31 NUMBER OF US HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (2020) 103
TABLE 32 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 104
9.3 LIVESTOCK ANIMALS 104
TABLE 33 POPULATION OF LARGE ANIMALS IN THE US, 2010–2018 (MILLION) 105
TABLE 34 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 105
TABLE 35 VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 106
9.3.1 CATTLE 106
9.3.1.1 Early diagnosis is crucial as cattle contribute more than 85% to the global milk supply 106
TABLE 36 VETERINARY REFERENCE LABORATORY MARKET FOR CATTLE, BY COUNTRY, 2019–2026 (USD MILLION) 107
9.3.2 PIGS 107
9.3.2.1 Growing need to check disease outbreaks to drive the growth of this market segment 107
TABLE 37 VETERINARY REFERENCE LABORATORY MARKET FOR PIGS, BY COUNTRY, 2019–2026 (USD MILLION) 108
9.3.3 POULTRY 108
9.3.3.1 Increasing focus on animal-derived protein sources from poultry will drive the growth of this market segment 108
FIGURE 35 GLOBAL POULTRY MEAT PRODUCTION, 2016 VS. 2017 VS. 2018 (MILLION METRIC TONS) 109
TABLE 38 VETERINARY REFERENCE LABORATORY MARKET FOR POULTRY, BY COUNTRY, 2019–2026 (USD MILLION) 109
9.3.4 SHEEP AND GOATS 110
9.3.4.1 Increasing prevalence of diseases in sheep and goats to drive the growth of this market segment 110
TABLE 39 VETERINARY REFERENCE LABORATORY MARKET FOR SHEEP AND GOATS,
BY COUNTRY, 2019–2026 (USD MILLION) 110
9.3.5 OTHER LIVESTOCK ANIMALS 111
TABLE 40 VETERINARY REFERENCE LABORATORY MARKET FOR OTHER LIVESTOCK ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION) 111
10 VETERINARY REFERENCE LABORATORY MARKET, BY REGION 112
10.1 INTRODUCTION 113
FIGURE 36 INDIA TO REGISTER THE HIGHEST GROWTH RATE IN THE VETERINARY REFERENCE LABORATORY MARKET DURING THE FORECAST PERIOD 113
TABLE 41 VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 114
10.2 NORTH AMERICA 114
FIGURE 37 EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA 115
FIGURE 38 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT 116
TABLE 42 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY COUNTRY, 2019–2026 (USD MILLION) 116
TABLE 43 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY SERVICE TYPE, 2019–2026 (USD MILLION) 117
TABLE 44 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION) 117
TABLE 45 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 46 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 118
TABLE 47 NORTH AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 118
10.2.1 US 118
10.2.1.1 The US dominated the veterinary reference laboratory
market in North America 118
TABLE 48 US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION) 119
FIGURE 39 US: PET OWNERSHIP INDICATORS, 2017–2018 119
TABLE 49 US: PRIVATE CLINICAL PRACTICES, BY ANIMAL TYPE, 2014–2019 120
TABLE 50 US: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 120
TABLE 51 US: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 121
TABLE 52 US: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 53 US: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 54 US: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 122
10.2.2 CANADA 122
10.2.2.1 Increasing population of livestock animals and adoption of pets
to drive market growth in Canada 122
TABLE 55 COMPANION ANIMAL POPULATION IN CANADA, 2016–2020 (MILLION) 122
TABLE 56 CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION) 123
TABLE 57 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 123
TABLE 58 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 123
TABLE 59 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 60 CANADA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 124
TABLE 61 CANADA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 125
10.3 EUROPE 125
FIGURE 40 EU-27: LIVESTOCK POPULATION, 2012–2019 (MILLION) 126
TABLE 62 EUROPE: NUMBER OF VETERINARIANS, 2012–2019 126
FIGURE 41 EUROPE: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT 127
TABLE 63 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 128
TABLE 64 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 128
TABLE 65 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 128
TABLE 66 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 67 EUROPE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 129
TABLE 68 EUROPE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 129
10.3.1 UK 130
10.3.1.1 The UK dominates the veterinary reference laboratory market in Europe 130
TABLE 69 UK: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION) 130
TABLE 70 UK: NUMBER OF VETERINARIANS, 2014 VS. 2019 130
TABLE 71 UK: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 131
TABLE 72 UK: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 131
TABLE 73 UK: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 131
TABLE 74 UK: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 75 UK: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 132
10.3.2 GERMANY 132
10.3.2.1 The majority of veterinary practices in Germany collaborate with reference laboratories for testing services 132
TABLE 76 GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 133
TABLE 77 GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019 133
TABLE 78 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 134
TABLE 79 GERMANY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 134
TABLE 80 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 81 GERMANY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 135
TABLE 82 GERMANY: VETERINARY REFERENCE LABORATORY MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 135
10.3.3 FRANCE 135
10.3.3.1 Rising pet ownership rate is one of the major drivers for market growth in France 135
TABLE 83 FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION) 136
TABLE 84 FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 136
TABLE 85 FRANCE: NUMBER OF VETERINARIANS, 2014 VS. 2017 136
TABLE 86 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 137
TABLE 87 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 137
TABLE 88 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 137
TABLE 89 FRANCE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 90 FRANCE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 138
10.3.4 ITALY 138
10.3.4.1 Disease outbreaks and rising meat consumption indicate demand for testing facilities in Italy 138
TABLE 91 ITALY: NUMBER OF VETERINARIANS, 2012 VS. 2017 139
TABLE 92 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 139
TABLE 93 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 139
TABLE 94 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 95 ITALY: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 96 ITALY: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 140
10.3.5 SPAIN 141
10.3.5.1 Increasing number of veterinary practices and willingness to spend on animal healthcare to propel market growth 141
TABLE 97 SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION) 141
TABLE 98 SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION) 142
TABLE 99 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 142
TABLE 100 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 142
TABLE 101 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 102 SPAIN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 143
TABLE 103 SPAIN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 143
10.3.6 REST OF EUROPE 144
TABLE 104 ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION) 144
TABLE 105 ROE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION) 144
TABLE 106 ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019 144
TABLE 107 ROE: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 145
TABLE 108 ROE: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 145
TABLE 109 ROE: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 145
TABLE 110 ROE: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 146
TABLE 111 ROE: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 146
10.4 ASIA PACIFIC 147
FIGURE 42 ASIA PACIFIC: VETERINARY REFERENCE LABORATORY MARKET SNAPSHOT 147
TABLE 112 APAC: VETERINARY REFERENCE LABORATORY MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 148
TABLE 113 APAC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 148
TABLE 114 APAC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 148
TABLE 115 APAC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 116 APAC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 117 APAC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 149
10.4.1 CHINA 150
10.4.1.1 China dominates the Asia Pacific market 150
TABLE 118 CHINA: LIVESTOCK POPULATION, 2010–2019 (MILLION) 150
TABLE 119 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 150
TABLE 120 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 151
TABLE 121 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 122 CHINA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 123 CHINA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 152
10.4.2 JAPAN 152
10.4.2.1 Rising demand for diagnosing zoonotic diseases in imported pet breeds is expected to drive market growth 152
TABLE 124 PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS IN JAPAN, 2000 VS. 2030 (THOUSAND METRIC TONS) 153
TABLE 125 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 153
TABLE 126 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 153
TABLE 127 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 128 JAPAN: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 154
TABLE 129 JAPAN: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 154
10.4.3 INDIA 155
10.4.3.1 India is an untapped market with huge growth potential 155
TABLE 130 INDIA: LIVESTOCK POPULATION, 2007–2019 (MILLION) 155
TABLE 131 INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS) 155
TABLE 132 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 156
TABLE 133 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 156
TABLE 134 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 135 INDIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 157
TABLE 136 INDIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 157
10.4.4 AUSTRALIA 158
10.4.4.1 Australia is one of the largest consumers of beef & mutton in the world 158
TABLE 137 AUSTRALIA: LIVESTOCK POPULATION, BY COUNTRY, 2010–2019 (MILLION) 158
TABLE 138 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 158
TABLE 139 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 159
TABLE 140 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 141 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 159
TABLE 142 AUSTRALIA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 160
10.4.5 REST OF APAC 160
TABLE 143 ROAPAC: LIVESTOCK POPULATION, BY COUNTRY, 2010–2019 (MILLION) 160
TABLE 144 ROAPAC: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 161
TABLE 145 ROAPAC: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 161
TABLE 146 ROAPAC: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 147 ROAPAC: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 162
TABLE 148 ROAPAC: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 162
10.5 LATIN AMERICA 163
10.5.1 RISING BEEF EXPORTS AND GROWING PET ADOPTION HAVE DRIVEN MARKET GROWTH IN LATAM 163
TABLE 149 LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY,
2010–2019 (MILLION) 163
TABLE 150 LATIN AMERICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2019 164
TABLE 151 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY SERVICE TYPE, 2019–2026 (USD MILLION) 164
TABLE 152 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 164
TABLE 153 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 154 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 165
TABLE 155 LATIN AMERICA: VETERINARY REFERENCE LABORATORY MARKET,
BY APPLICATION, 2019–2026 (USD MILLION) 165
10.6 MIDDLE EAST & AFRICA 166
10.6.1 RELUCTANCE TO SPEND ON PET HEALTH HAS SLOWED THE PACE OF MARKET GROWTH 166
TABLE 156 MIDDLE EAST: LIVESTOCK ANIMAL POPULATION, 2010 VS. 2019 166
TABLE 157 AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION) 167
TABLE 158 AFRICA: NUMBER OF VETERINARIANS AND PARAVETERINARIANS,
2010–2018 167
TABLE 159 MEA: VETERINARY REFERENCE LABORATORY MARKET, BY SERVICE TYPE, 2019–2026 (USD MILLION) 167
TABLE 160 MEA: VETERINARY REFERENCE LABORATORY MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION) 168
TABLE 161 MEA: VETERINARY REFERENCE LABORATORY MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 162 MEA: VETERINARY REFERENCE LABORATORY MARKET FOR LIVESTOCK ANIMALS, BY TYPE, 2019–2026 (USD MILLION) 168
TABLE 163 MEA: VETERINARY REFERENCE LABORATORY MARKET, BY APPLICATION, 2019–2026 (USD MILLION) 169
11 COMPETITIVE LANDSCAPE 170
11.1 INTRODUCTION 170
FIGURE 43 KEY MARKET DEVELOPMENTS (JANUARY 2018 TO NOVEMBER 2021) 170
11.2 REVENUE ANALYSIS OF KEY MARKET PLAYERS 171
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN THE VETERINARY REFERENCE LABORATORY MARKET 171
11.3 MARKET SHARE ANALYSIS (FOR COMPANION ANIMALS) 171
FIGURE 45 VETERINARY REFERENCE LABORATORY MARKET SHARE,
BY KEY PLAYER, 2020 172
11.4 COMPETITIVE SCENARIO 173
11.4.1 SERVICE LAUNCHES 173
TABLE 164 VETERINARY REFERENCE LABORATORY MARKET: SERVICE LAUNCHES (JANUARY 2018 TO NOVEMBER 2021) 173
11.4.2 DEALS 174
TABLE 165 VETERINARY REFERENCE LABORATORY MARKET: DEALS (JANUARY 2018 TO NOVEMBER 2021) 174
11.4.3 OTHER DEVELOPMENTS 175
TABLE 166 VETERINARY REFERENCE LABORATORY MARKET: OTHER DEVELOPMENTS (JANUARY 2018 TO NOVEMBER 2021) 175
11.5 COMPETITIVE BENCHMARKING 176
11.6 VETERINARY REFERENCE LABORATORY MARKET: R&D EXPENDITURE 182
11.6.1 R&D EXPENDITURE OF KEY PLAYERS IN THE VETERINARY REFERENCE LABORATORY MARKET (2019 VS. 2020) 182
11.7 COMPANY EVALUATION MATRIX 183
11.7.1 STARS 183
11.7.2 EMERGING LEADERS 183
11.7.3 PERVASIVE PLAYERS 183
11.7.4 EMERGING COMPANIES 183
FIGURE 46 VETERINARY REFERENCE LABORATORY MARKET: GLOBAL COMPANY EVALUATION MATRIX 184
11.8 COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 185
11.8.1 PROGRESSIVE COMPANIES 185
11.8.2 STARTING BLOCKS 185
11.8.3 RESPONSIVE COMPANIES 185
11.8.4 DYNAMIC COMPANIES 185
FIGURE 47 VETERINARY REFERENCE LABORATORY MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS 186
12 COMPANY PROFILES 187
12.1 INTRODUCTION 187
TABLE 167 MAJOR PUBLIC, PRIVATE, AND GOVERNMENT-AIDED PLAYERS IN THE VETERINARY REFERENCE LABORATORIES MARKET 187
12.2 KEY PLAYERS 188
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.2.1 IDEXX LABORATORIES, INC. 188
TABLE 168 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW 188
FIGURE 48 COMPANY SNAPSHOT: IDEXX LABORATORIES, INC. (2020) 189
12.2.2 VCA, INC. (A PART OF MARS PETCARE) 195
TABLE 169 VCA, INC.: BUSINESS OVERVIEW 195
12.2.3 BOEHRINGER INGELHEIM 198
TABLE 170 BOEHRINGER INGELHEIM: BUSINESS OVERVIEW 198
FIGURE 49 COMPANY SNAPSHOT: BOEHRINGER INGELHEIM (2020) 199
12.2.4 GD ANIMAL HEALTH 204
TABLE 171 GD ANIMAL HEALTH: BUSINESS OVERVIEW 204
12.2.5 ZOETIS INC. 206
TABLE 172 ZOETIS INC.: BUSINESS OVERVIEW 206
FIGURE 50 COMPANY SNAPSHOT: ZOETIS INC. (2020) 207
12.2.6 NEOGEN CORPORATION 213
TABLE 173 NEOGEN CORPORATION: BUSINESS OVERVIEW 213
FIGURE 51 COMPANY SNAPSHOT: NEOGEN CORPORATION (2020) 214
12.2.7 LABOKLIN GMBH 219
TABLE 174 LABOKLIN GMBH: BUSINESS OVERVIEW 219
12.2.8 SYNLAB INTERNATIONAL GMBH 223
TABLE 175 SYNLAB INTERNATIONAL GMBH: BUSINESS OVERVIEW 223
12.2.9 HESKA CORPORATION 225
TABLE 176 HESKA CORPORATION: BUSINESS OVERVIEW 225
FIGURE 52 COMPANY SNAPSHOT: HESKA CORPORATION (2020) 226
12.2.10 VIRBAC 229
TABLE 177 VIRBAC: BUSINESS OVERVIEW 229
FIGURE 53 COMPANY SNAPSHOT: VIRBAC (2020) 230
12.3 OTHER PLAYERS 231
12.3.1 THERMO FISHER SCIENTIFIC, INC. 231
TABLE 178 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 231
FIGURE 54 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC, INC. (2020) 232
12.3.2 TEXAS A&M VETERINARY MEDICAL DIAGNOSTIC LABORATORY 234
TABLE 179 TVMDL: BUSINESS OVERVIEW 234
12.3.3 UNIVERSITY OF MINNESOTA (VETERINARY DIAGNOSTIC LABORATORY) 237
TABLE 180 UNIVERSITY OF MINNESOTA’S VETERINARY DIAGNOSTIC
LABORATORY: BUSINESS OVERVIEW 237
12.3.4 IOWA STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORY) 239
TABLE 181 IOWA STATE UNIVERSITY’S VETERINARY DIAGNOSTIC LABORATORY: BUSINESS OVERVIEW 239
12.3.5 VETNOSTICS 241
12.3.6 IDVET 242
12.3.7 PROTATEK INTERNATIONAL INC. 243
12.3.8 ANIMAL AND PLANT HEALTH AGENCY 243
12.3.9 ANIMAL HEALTH DIAGNOSTIC CENTER (CORNELL UNIVERSITY) 244
12.3.10 NATIONAL VETERINARY SERVICES LABORATORY USDA-APHIS 245
12.3.11 WASHINGTON ANIMAL DISEASE DIAGNOSTIC LABORATORY (WADDL) 246
12.3.12 COLORADO STATE UNIVERSITY (VETERINARY DIAGNOSTIC LABORATORIES) 247
12.3.13 THE PIRBRIGHT INSTITUTE 248
12.3.14 FRIEDRICH-LOEFFLER-INSTITUT (FLI) 249
12.3.15 KANSAS STATE VETERINARY DIAGNOSTIC LABORATORY 250
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 251
13.1 DISCUSSION GUIDE 251
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 257
13.3 AVAILABLE CUSTOMIZATIONS 259
13.4 RELATED REPORTS 259
13.5 AUTHOR DETAILS 260

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127